{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:05:09Z","timestamp":1793034309431,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DPIP\/ISEC Programme of the European Union"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s13181-018-0674-4","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T09:40:42Z","timestamp":1533030042000},"page":"4-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Concurrent Use of Benzodiazepine by Heroin Users\u2014What Are the Prevalence and the Risks Associated with This Pattern of Use?"],"prefix":"10.1007","volume":"15","author":[{"name":"On behalf of the Euro-DEN Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. I.","family":"Dargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Heyerdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Hovda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Giraudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sedefov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7826-7237","authenticated-orcid":false,"given":"D. M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"674_CR1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5694\/j.1326-5377.1996.tb94136.x","volume":"164","author":"D Zador","year":"1996","unstructured":"Zador D, Sunjic S, Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996;164:204\u20137.","journal-title":"Med J Aust"},{"issue":"3","key":"674_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/09595239600185971","volume":"15","author":"J Ross","year":"1996","unstructured":"Ross J, Darke S, Hall W. Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement. Drug Alcohol Rev. 1996;15(3):237\u201343.","journal-title":"Drug Alcohol Rev"},{"key":"674_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1360-0443.1996.tb02289.x","volume":"91","author":"S Darke","year":"1996","unstructured":"Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91:405\u201311.","journal-title":"Addiction"},{"key":"674_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1465-3362.2009.00101.x","volume":"29","author":"S Darke","year":"2010","unstructured":"Darke S, Ross J, Mills K, Teesson M, Williamson A, Havard A. Benzodiazepine use among heroin users: baseline use, current use and clinical outcome. Drug Alcohol Rev. 2010;29:250\u20135.","journal-title":"Drug Alcohol Rev"},{"key":"674_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drugalcdep.2014.09.001","volume":"144","author":"S Darke","year":"2014","unstructured":"Darke S, Marel C, Mills KL, Ross J, Slade T, Burns L, et al. Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: findings from the Australian Treatment Outcome Study. Drug Alcohol Depend. 2014;144:148\u201352.","journal-title":"Drug Alcohol Depend"},{"key":"674_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0376-8716(93)90090-D","volume":"32","author":"MY Iguchi","year":"1993","unstructured":"Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use\/abuse by methadone maintenance clients. Drug Alcohol Depend. 1993;32:257\u201366.","journal-title":"Drug Alcohol Depend"},{"key":"674_CR7","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1046\/j.1360-0443.2000.951217858.x","volume":"95","author":"J Ross","year":"2000","unstructured":"Ross J, Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction. 2000;95:1785\u201393.","journal-title":"Addiction"},{"key":"674_CR8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","volume":"38","author":"M Vogel","year":"2013","unstructured":"Vogel M, Kn\u00f6pfli B, Schmid O, Prica M, Strasser J, Prieto L, et al. Treatment or \u201chigh\u201d: benzodiazepine use in patients on injectable heroin or oral opioids. Addict Behav. 2013;38:2477\u201384.","journal-title":"Addict Behav"},{"key":"674_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0376-8716(99)00147-7","volume":"60","author":"S Darke","year":"2000","unstructured":"Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992\u20131996. Drug Alcohol Depend. 2000;60:141\u201350.","journal-title":"Drug Alcohol Depend"},{"key":"674_CR10","unstructured":"EMCDDA, Perspectives on drugs. Opioid trafficking routes from Asia to Europe, in European Monitoring Centre for Drugs and Drug Addiction. 2015. \n                    http:\/\/www.emcdda.europa.eu\/topics\/pods\/opioid-trafficking-routes\n                    \n                   [last accessed 27th April 2018]."},{"key":"674_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","volume":"94","author":"JM White","year":"1999","unstructured":"White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94:961\u201372.","journal-title":"Addiction"},{"key":"674_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0147-9563(97)90089-3","volume":"26","author":"K Puntillo","year":"1997","unstructured":"Puntillo K, Casella V, Reid M. Opioid and benzodiazepine tolerance and dependence: application of theory to critical care practice. Heart Lung: J Acute Crit Care. 1997;26:317\u201324.","journal-title":"Heart Lung: J Acute Crit Care"},{"key":"674_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/BF02939579","volume":"168","author":"S Rooney","year":"1999","unstructured":"Rooney S, Kelly G, Bamford L, Sloan D, O\u2019Connor JJ. Co-abuse of opiates and benzodiazepines. Ir J Med Sci. 1999;168:36\u201341.","journal-title":"Ir J Med Sci"},{"key":"674_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1046\/j.1360-0443.2003.00430.x","volume":"98","author":"S Darke","year":"2003","unstructured":"Darke S, Ross J, Teesson M, Lynskey M. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction. 2003;98:1129\u201335.","journal-title":"Addiction"},{"key":"674_CR15","unstructured":"EMCDDA, The misuse of benzodiazepines among high-risk opioid users in Europe, in European Monitoring Centre for Drugs and Drug Addiction. 2015. \n                    http:\/\/www.emcdda.europa.eu\/topics\/pods\/benzodiazepines\n                    \n                   [last accessed 27th April 2018]."},{"key":"674_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1472-8206.2010.00882.x","volume":"25","author":"E Frauger","year":"2011","unstructured":"Frauger E, Pauly V, Pradel V, Rouby F, Arditti J, Thirion X, et al. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network. Fundam Clin Pharmacol. 2011;25:633\u201341.","journal-title":"Fundam Clin Pharmacol"},{"key":"674_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00004714-199212000-00005","volume":"12","author":"C Barnas","year":"1992","unstructured":"Barnas C, et al. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol. 1992;12:397\u2013402.","journal-title":"J Clin Psychopharmacol"},{"key":"674_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.20882\/adicciones.241","volume":"21","author":"AM Fernandez Sobrino","year":"2009","unstructured":"Fernandez Sobrino AM, Fernandez Rodriguez V, Lopez Castro J. Benzodiazepine use in a sample of patients on a treatment program with opiate derivatives (PTDO). Adicciones. 2009;21:143\u20136.","journal-title":"Adicciones"},{"key":"674_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0376-8716(98)00175-6","volume":"55","author":"M Gelkopf","year":"1999","unstructured":"Gelkopf M, Bleich A, Hayward R, Bodner G, Adelson M. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend. 1999;55:63\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"674_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1185\/03007999009112687","volume":"11","author":"V Navaratnam","year":"1990","unstructured":"Navaratnam V, Foong K. Adjunctive drug use among opiate addicts. Curr Med Res Opin. 1990;11:611\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"2\u20133","key":"674_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.drugalcdep.2007.03.008","volume":"90","author":"JG Bramness","year":"2007","unstructured":"Bramness JG, Kornor H. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend. 2007;90(2\u20133):203\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"674_CR22","unstructured":"EMCDDA, Trendspotter summary report, in European Monitoring Centre for Drugs and Drug Addiction. 2011. \n                    http:\/\/www.emcdda.europa.eu\/scientific-studies\/2011\/trendspotters-report\n                    \n                   [Last accessed 27th April 2018]."},{"key":"674_CR23","unstructured":"United Nations Office of Drugs and Crime, World drug report 2012. 2012. \n                    https:\/\/www.unodc.org\/unodc\/en\/about-unodc\/index.html?ref=menutop\n                    \n                   [Last accessed 27th April 2018]."},{"key":"674_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1300\/J069v24n04_02","volume":"24","author":"M Backmund","year":"2005","unstructured":"Backmund M, Meyer K, Henkel C, Soyka M, Reimer J, Sch\u00fctz CG. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis. 2005;24:17\u201329.","journal-title":"J Addict Dis"},{"key":"674_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/15563650.2014.898771","volume":"52","author":"DM Wood","year":"2014","unstructured":"Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE, et al. The European Drug Emergencies Network (Euro-DEN). Clin Toxicol (Phila). 2014;52:239\u201341.","journal-title":"Clin Toxicol (Phila)"},{"key":"674_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3109\/15563650.2015.1088157","volume":"53","author":"AM Dines","year":"2015","unstructured":"Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, et al. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clin Toxicol (Phila). 2015;53:893\u2013900.","journal-title":"Clin Toxicol (Phila)."},{"key":"674_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000377628","volume":"21","author":"G Hoiseth","year":"2015","unstructured":"Hoiseth G, et al. Has previous abuse of flunitrazepam been replaced by clonazepam? Eur Addict Res. 2015;21:217\u201321.","journal-title":"Eur Addict Res"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-018-0674-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T19:07:39Z","timestamp":1564513659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-018-0674-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1007\/s13181-018-0674-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained by each centre to collect the data as part of Euro-DEN project.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"PID and DMW work with the European Monitoring Centre for Drugs and Drug Addiction and the UK Advisory Council for the Misuse of Drugs. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}